Filing Details
- Accession Number:
- 0001357211-12-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-31 18:26:59
- Reporting Period:
- 2012-08-31
- Filing Date:
- 2012-08-31
- Accepted Time:
- 2012-08-31 18:26:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1159019 | Stellar Pharmaceuticals Inc | SLXCF | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1489399 | Harold Steven Goldman | 22 Vesta Drive Toronto A6 M5P 2Z5 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Acquisiton | 2012-08-31 | 15,000 | $0.46 | 980,146 | No | 4 | P | Indirect | Lambent Consulting Corp |
Common Shares | Acquisiton | 2012-08-31 | 5,000 | $0.49 | 985,146 | No | 4 | P | Indirect | Lambent Consulting Corp |
Common Shares | Acquisiton | 2012-08-31 | 15,000 | $0.49 | 1,000,146 | No | 4 | P | Indirect | Lambent Consulting Corp |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Lambent Consulting Corp |
No | 4 | P | Indirect | Lambent Consulting Corp |
No | 4 | P | Indirect | Lambent Consulting Corp |